(Q34477386)

2 August 2017

1 reference

title

Endometrial adenocarcinoma: a primer for the generalist (English)

1 reference

endometrial adenocarcinoma

2 August 2017

1 reference

1 reference

Hernandez E

1

1 reference

2 August 2017

publication date

1 December 2001

1 reference

Obstetrics and Gynecology Clinics of North America

2 August 2017

published in

1 reference

2 August 2017

volume

28

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

743-757

1 reference

Endometrial carcinoma--relative effectiveness of adjuvant irradiation vs therapy reserved for relapse

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Influence of postoperative treatment on survival in patients with uterine papillary serous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Contemporary issues in the management of endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Clinical Stage I adenocarcinoma of the endometrium—Analysis of recurrences and the potential benefit of staging lymphadenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Prognostic factors and long-term survival in endometrial adenocarcinoma with cervical involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Stage IVB endometrial carcinoma: the role of cytoreductive surgery and determinants of survival

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

How should we monitor women treated for endometrial carcinoma?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Multiple primary neoplasms of the ovary and uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Computed tomography in endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Cisplatin, Adriamycin, Etoposide, Megestrol Acetate versus Melphalan, 5-Fluorouracil, Medroxyprogesterone Acetate in the Treatment of Endometrial Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Metastatic endometrial cancer in lung and liver: complete and prolonged response to hormonal therapy with progestins

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Paclitaxel and Cisplatin in Advanced or Recurrent Carcinoma of the Endometrium: Long-Term Results of a Phase II Multicenter Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Uterine papillary serous carcinoma: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Simultaneous presentation of carcinoma involving the ovary and the uterine corpus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Endometrial carcinoma: treatment of positive paraaortic nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

A comparative study between panoramic hysteroscopy with directed biopsies and dilatation and curettage. A review of 276 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Uterine papillary serous carcinoma: evaluation of long-term survival in surgically staged patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

The Role of Adjuvant Radiotherapy in Carcinoma of the Endometrium—Results in 550 Patients with Pathologic Stage I Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Endometrial carcinoma associated with hyperplasia--immunohistochemical study of angiogenesis and p53 expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

A case-control study of endometrial cancer in relation to reproductive, somatometric, and life-style variables

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Benefit of external irradiation in pathologic stage I endometrial carcinoma: a prospective clinical trial of 605 patients who received postoperative vaginal irradiation and additional pelvic irradiation in the presence of unfavorable prognostic fact

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Transvaginal ultrasonography compared with endometrial biopsy for the detection of endometrial disease. Postmenopausal Estrogen/Progestin Interventions Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Surgery without radiotherapy for primary treatment of endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Hysterectomy with extended surgical staging and radiotherapy versus hysterectomy alone and radiotherapy in stage I endometrial cancer: a comparison of complication rates

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

An Analysis of Approaches to the Management of Endometrial Cancer in North America: A CTF Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Staging laparotomy for endometrial carcinoma: assessment of peritoneal spread

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Stage I corpus cancer: is teletherapy necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

A prospective trial of progesterone therapy for malignant peritoneal cytology in patients with endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Detection and patterns of treatment failure in 300 consecutive cases of "early" endometrial cancer after primary surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Tamoxifen therapy in advanced/recurrent endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Role of intracavitary cuff boost after adjuvant external irradiation in early endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Surveillance for Recurrent Endometrial Carcinoma: Development of a Follow-up Scheme

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

A new aggressive treatment approach to high-grade endometrial cancer of possible benefit to patients with stage I uterine papillary cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Value of preoperative CA 125 level in the management of uterine cancer and prediction of clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Risk factors for endometrial hyperplasia and cancer among women with abnormal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

Malignant peritoneal cytology as prognostic indicator in stage I endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970233-3

7 January 2021

10.1016/S0889-8545(05)70233-3

Identifiers

DOI

1 reference

2 August 2017

1 reference